ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Initial public offerings (IPOs) of start-up firms fell by more than half in the first quarter of 2013 compared with the previous quarter and the first quarter of 2012, according to a new survey. First-quarter activity is often subdued, notes John S. Taylor, head of research at the National Venture Capital Association, which conducted the survey of start-ups along with Thomson Reuters. “This year, political, taxation, and sequestration concerns weighed even more heavily on the exit market for emerging companies,” Taylor says. The dollar value of the eight IPOs in the quarter was $672 million, down 52% from the previous quarter and 60% from the first quarter of 2012. Six of the IPOs were in the information technology sector and two were in life sciences. Acquisitions of 10 start-ups in the quarter were worth $983 million, down more than 70% compared with the values reported in the first and fourth quarters of last year. Most deals involved IT, but four—including the largest, Illumina’s $350 million purchase of Verinata Health—were in the life sciences.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter